Lacosamide 60505-6235
Product NDC
60505-6235- Manufacturer
- Apotex Corp
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- February 20, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA216670
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(1)
10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6235-4) / 20 mL in 1 VIAL, SINGLE-DOSE